RICCARDI, NICCOLO'
RICCARDI, NICCOLO'
Universita' degli Studi di MILANO
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic
2020 D. Canetti, R. Dell'Acqua, N. Riccardi, L. Della Torre, A. Bigoloni, C. Muccini, E. Bruzzesi, M. Ranzenigo, M. Chiurlo, S. Racca, C. Galli, A. Castagna, G. Tambussi, A. Lazzarin
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: different effects in different patients populations : results from a large observational study
2019 L. Taramasso, A. Di Biagio, N. Riccardi, F. Briano, E. Di Filippo, L. Comi, S. Mora, M. Giacomini, A. Gori, F. Maggiolo
Magnusiomyces clavatus infection in a child after allogeneic hematotopoetic stem cell transplantation: Diagnostic and therapeutic implications
2019 M. Leoni, N. Riccardi, G.A. Rotulo, E. Godano, M. Faraci, R. Bandettini, M.C. Esposto, E. Castagnola
A rare case of multi-focal human TB after BCG instillation for non-muscle-invasive bladder cancer
2019 N. Riccardi, M. Ferrarese, P. Castellotti, E. Mazzola, F. Sozzi, P. Rigatti, A. Vanzulli, G. Sotgiu, L. Codecasa
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/ emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia
2019 L. Taramasso, A. Di Biagio, N. Riccardi, F. Briano, E. Di Filippo, L. Comi, S. Mora, M. Giacomini, A. Gori, F. Maggiolo
Maintenance of viral suppression after optimization therapy from etravirine plus raltegravir to rilpivirine plus dolutegravir in HIV-1-infected patients
2019 N. Riccardi, F. Del Puente, L. Taramasso, A. Di Biagio
Is it time to re-think the use of etravirine in patients with available genotypic resistance test?
2019 F. Del Puente, N. Riccardi, L. Taramasso, A. Borghetti, A. D'Avino, S. Irene Bonelli, A. De Luca, M. Zazzi, A. Di Biagio
Bedaquiline : a new hope for shorter and better anti-tuberculosis regimens
2018 N. Riccardi, F. Del Puente, F. Magne, L. Taramasso, A. Di Biagio
Ibalizumab and fostemsavir in the management of heavily pre-treated HIV-infected patients
2018 N. Riccardi, M. Berruti, F. Del Puente, L. Taramasso, A. Di Biagio
Short Communication : Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis?
2018 L. Taramasso, N. Riccardi, F. Del Puente, B. Bruzzone, D. Ripamonti, B. D'Ambrosio, C. Viscoli, A. Di Biagio
Hypertensive versus HIV-infected patients : Who has the greatest target organ damage? Comparison of carotid plaque prevalence, intima media thickness and renal resistive index in the two groups of patients
2018 L. Taramasso, M. Mirabella, F. Cappadona, B. Bonino, N. Riccardi, G. Cenderello, G.V. De Socio, C. Viscoli, F. Viazzi, A. Di Biagio
Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjects
2018 A.F. Capetti, G.V. De Socio, M.V. Cossu, G. Sterrantino, G. Cenderello, A. Cattelan, G.M. Baldin, A. Soria, N. Riccardi, F.P. Niero, B.M. Celesia, G. Barbarini, S. Rusconi, G. Rizzardini
Time to change the single-centre approach to management of patients with tuberculosis : a novel network platform with automatic data import and data sharing
2018 N. Riccardi, B. Giannini, M.L. Borghesi, L. Taramasso, E. Cattaneo, G. Cenderello, F. Toscanini, M. Giacomini, E. Pontali, G. Cassola, C. Viscoli, A. Di Biagio
Role of raltegravir in patients co-infected with HIV and HCV in the era of direct antiviral agents
2017 L. Taramasso, G. Cenderello, N. Riccardi, S. Tunesi, A. Di Biagio
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area
2017 L. Sticchi, I. Barberis, F. Grammatico, V. Tirsa, A. Di Biagio, G. Cenderello, M. Giacomini, B. Giannini, F. Iavarone, V. Faccio, L.A. Nicolini, N. Riccardi, L. Taramasso, B. Bruzzone, G. Mazzarello, G. Cassola, C. Viscoli, G. Icardi
Increasing prevalence of genitourinary schistosomiasis in Europe in the Migrant Era : Neglected no more?
2017 N. Riccardi, F. Nosenzo, F. Peraldo, F. Sarocchi, L. Taramasso, P. Traverso, C. Viscoli, A. Di Biagio, L.E. Derchi, A. De Maria
PrEP in Italy: The time may be ripe but who’s paying the bill? A nationwide survey on physicians’ attitudes towards using antiretrovirals to prevent HIV infection
2017 A. Di Biagio, N. Riccardi, A. Signori, R. Maserati, S. Nozza, A. Gori, S. Bonora, M. Borderi, D. Ripamonti, M. Rossi, G. Orofino, T. Quirino, G. Nunnari, B. Celesia, S. Martini, C. Sagnelli, G. Mazzola, P. Colletti, D. Bartolozzi, T. Bini, N. Ladisa, F. Castelnuovo, A. Saracino, S. Lo Caputo
Chemotherapy Mass Campaigns and Migratory Flows : An Unexpected Connection
2016 G. Cenderello, L. Taramasso, N. Riccardi, A. Di Biagio, G. Cassola, A. De Maria
Increasing use and accessibility of anti parasitic drugs for migrants with neglected diseases at a time of migratory emergency
2016 G. Cenderello, A. Di Biagio, N. Riccardi, L. Taramasso, A. De Maria, G. Cassola, C. Viscoli
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides
2016 A. Di Biagio, N. Riccardi, L. Taramasso, A. Capetti, G. Cenderello, A. Signori, P. Vitiello, M. Guerra, G.V. de Socio, G. Cassola, T. Quirino, C. Viscoli